American Surgical Association (ASA)
Home
Annual Meeting
Council
Committees
Members Only
Membership
Journal
Transactions
Foundation
Awards
Newsletter
About / History

Search ASA
 
130th Annual Meeting Abstracts


Bariatric Surgery is Safe and Effective Treatment for Diabetes in Non-morbidly Obese Patients: Results reported by ASMBS Bariatric Surgery Centers of Excellence (BSCOE) in Bariatric Outcomes Longitudinal Database (BOLD)
*Eric J DeMaria1, *Deborah Winegar2, *Virginia Pate2, *Quinn Sanger2, Walter J Pories3
1Duke University, Durham, NC;2Surgical Review Corporation, Raleigh, NC;3East Carolina University, Greenville, NC

OBJECTIVE(S):
Small case series suggest bariatric surgery may be effective treatment for diabetes in patients who do not meet criteria for morbid obesity (BMI < 35 kg/M2), but large multi-institutional series, which allow better assessment of the safety / efficacy of treatment, have not been reported.
METHODS:
Data from 66,264 research-consented patients with a surgery encounter in BOLD were queried to identify patients with BMI > 30 but < 35 kg/m2 (1.2%, n=794) and diabetes (DM) requiring any medication (29% of group).
RESULTS:
235 patients met inclusion criteria. The 2 most common procedures (adjustable gastric banding AGB, n=109 and gastric bypass, n=109) were compared. Laparoscopic access was utilized in 92% of procedures. Gender (77% female), race (80% Caucasian), and age (mean 52.6 + 10.4 yrs) did not differ between procedure groups.
Table: Data reported at baseline (BL) and at intervals < 12 months following surgery. (*p<0.05 vs. BL, α p<0.05 bypass vs. band)
CONCLUSIONS:
Remission (cessation of medications) of DM was reported in 47.8% of patients within 6-12 months of surgery. Gastric bypass provided superior weight loss and DM remission, but demonstrated more frequent complications (90-day AE: 12% vs. 3%, p<0.05). No mortalities were reported. The data suggest successful surgical treatment of diabetes in patients not meeting criteria for morbid obesity. Gastric bypass provides more effective early treatment for DM within 6-12 months.
nBMI# DM meds% DM remission
AGBBypassAGBBypassAGBBypassAGBBypass
BL10910933.9±1.233.7±1.11.34±1.141.51±1.15--
0-3 mos908831.6±2.5*30.6±3.0* α0.96±1.11*0.76±1.02*21.137.5* α
3-6 mos634431.0±2.7*27.2±3.8* α0.76±1.04*0.39±0.65*α31.8*50.0*
6-12 mos402930.9±2.9*27.1±4.5*α0.60±0.81*0.48±0.69*27.5*55.2*α


   

 
© Copyright 2019. Privacy Policy
American Surgical Association
500 Cummings Center, Suite 4400, Beverly, MA 01915
(978) 927-8330 | FAX (978) 524-0498
Email ASA
11:29:47 AM
Saturday, August 17, 2019